Back
Leap Therapeutics 10K Form
Buy
55
LPTX
Leap Therapeutics
Last Price:
$3.43
Seasonality Move:
-7.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LPTX News And Ratings
See the #1 stock for the next 7 days that we like better than LPTX
LPTX Financial Statistics
Sales & Book Value
Annual Sales: | $1.5M |
---|---|
Cash Flow: | $-15.6M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.28 |
Price / Book: | 2.63 |
Profitability
EPS (TTM): | -1.67000 |
---|---|
Net Income (TTM): | $-64.6M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Leap Therapeutics Earnings Forecast
Key Leap Therapeutics Financial Ratios
-
The Interest Expense is 0.00% of Operating Income.
-
Per Share Earnings over the last 12 years have been positive in 6 years.
Leap Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | LPTX |
CUSIP: | 52187K |
Website: | leaptx.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
LPTX Technical Analysis vs Fundamental Analysis
Buy
55
Leap Therapeutics (LPTX)
is a Buy
Is Leap Therapeutics a Buy or a Sell?
-
Leap Therapeutics stock is rated a BuyThe current Leap Therapeutics [LPTX] share price is $3.48. The Score for LPTX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.